source name	characteristics[organism]	characteristics[organism part]	characteristics[individual]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[disease]	characteristics[depletion]	characteristics[biological replicate]	characteristics[sampling time]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[label]	comment[technical replicate]	comment[cleavage agent details]	comment[instrument]	comment[separation]	comment[proteomics data acquisition method]	comment[modification parameter]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD029009-Sample-1	Homo sapiens	blood plasma	1	not applicable	not available	79	male	not available	COVID-19	Alive	no depletion	1	not applicable	20200520_TOF1_AF_129_ZeBanC_P2_A8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_129_ZeBanC_P2_A8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_129_ZeBanC_P2_A8.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-2	Homo sapiens	blood plasma	1	not applicable	not available	79	male	not available	COVID-19	Alive	no depletion	1	not applicable	20200520_TOF1_AF_144_ZeBanC_P2_B8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_144_ZeBanC_P2_B8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_144_ZeBanC_P2_B8.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-3	Homo sapiens	blood plasma	1	not applicable	not available	79	male	not available	COVID-19	Alive	no depletion	1	not applicable	20200520_TOF1_AF_167_ZeBanC_P2_D3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_167_ZeBanC_P2_D3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_167_ZeBanC_P2_D3.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-4	Homo sapiens	blood plasma	1	not applicable	not available	79	male	not available	COVID-19	Alive	no depletion	1	not applicable	20200520_TOF1_AF_175_ZeBanC_P2_D9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_175_ZeBanC_P2_D9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_175_ZeBanC_P2_D9.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-5	Homo sapiens	blood plasma	1	not applicable	not available	79	male	not available	COVID-19	Alive	no depletion	1	not applicable	20200520_TOF1_AF_209_ZeBanC_P2_G1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_209_ZeBanC_P2_G1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_209_ZeBanC_P2_G1.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-6	Homo sapiens	blood plasma	1	not applicable	not available	79	male	not available	COVID-19	Alive	no depletion	1	not applicable	20200520_TOF1_AF_210_ZeBanC_P2_G2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_210_ZeBanC_P2_G2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_210_ZeBanC_P2_G2.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-7	Homo sapiens	blood plasma	1	not applicable	not available	79	male	not available	COVID-19	Alive	no depletion	1	not applicable	20200520_TOF1_AF_220_ZeBanC_P2_G9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_220_ZeBanC_P2_G9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_220_ZeBanC_P2_G9.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-8	Homo sapiens	blood plasma	1	not applicable	not available	79	male	not available	COVID-19	Alive	no depletion	1	not applicable	20200520_TOF1_AF_231_ZeBanC_P2_H6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_231_ZeBanC_P2_H6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_231_ZeBanC_P2_H6.raw	1	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-9	Homo sapiens	blood plasma	1	not applicable	not available	79	male	not available	COVID-19	Alive	no depletion	1	not applicable	20200520_TOF1_AF_238_ZeBanC_P2_H12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_238_ZeBanC_P2_H12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_238_ZeBanC_P2_H12.raw	1	AC=MS:1002038;NT=label free sample	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-10	Homo sapiens	blood plasma	2	not applicable	not available	21	male	not available	COVID-19	Alive	no depletion	2	not applicable	20200520_TOF1_AF_158_ZeBanC_P2_C7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_158_ZeBanC_P2_C7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_158_ZeBanC_P2_C7.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-11	Homo sapiens	blood plasma	2	not applicable	not available	21	male	not available	COVID-19	Alive	no depletion	2	not applicable	20200520_TOF1_AF_163_ZeBanC_P2_C11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_163_ZeBanC_P2_C11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_163_ZeBanC_P2_C11.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-12	Homo sapiens	blood plasma	2	not applicable	not available	21	male	not available	COVID-19	Alive	no depletion	2	not applicable	20200520_TOF1_AF_176_ZeBanC_P2_D10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_176_ZeBanC_P2_D10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_176_ZeBanC_P2_D10.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-13	Homo sapiens	blood plasma	3	not applicable	not available	37	female	not available	COVID-19	Alive	no depletion	3	not applicable	20200520_TOF1_AF_128_ZeBanC_P2_A7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_128_ZeBanC_P2_A7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_128_ZeBanC_P2_A7.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-14	Homo sapiens	blood plasma	3	not applicable	not available	37	female	not available	COVID-19	Alive	no depletion	3	not applicable	20200520_TOF1_AF_160_ZeBanC_P2_C9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_160_ZeBanC_P2_C9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_160_ZeBanC_P2_C9.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-15	Homo sapiens	blood plasma	3	not applicable	not available	37	female	not available	COVID-19	Alive	no depletion	3	not applicable	20200520_TOF1_AF_169_ZeBanC_P2_D4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_169_ZeBanC_P2_D4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_169_ZeBanC_P2_D4.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-16	Homo sapiens	blood plasma	4	not applicable	not available	58	female	not available	COVID-19	Alive	no depletion	4	not applicable	20200520_TOF1_AF_452_ZeBanC_P4_B6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_452_ZeBanC_P4_B6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_452_ZeBanC_P4_B6.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-17	Homo sapiens	blood plasma	5	not applicable	not available	22	male	not available	COVID-19	Alive	no depletion	5	not applicable	20200520_TOF1_AF_245_ZeBanC_P5_A9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_245_ZeBanC_P5_A9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_245_ZeBanC_P5_A9.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-18	Homo sapiens	blood plasma	6	not applicable	not available	33	female	not available	COVID-19	Alive	no depletion	6	not applicable	20200520_TOF1_AF_454_ZeBanC_P4_B7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_454_ZeBanC_P4_B7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_454_ZeBanC_P4_B7.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-19	Homo sapiens	blood plasma	7	not applicable	not available	72	female	not available	COVID-19	Alive	no depletion	7	not applicable	20200520_TOF1_AF_505_ZeBanC_P4_E12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_505_ZeBanC_P4_E12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_505_ZeBanC_P4_E12.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-20	Homo sapiens	blood plasma	8	not applicable	not available	82	female	not available	COVID-19	Alive	no depletion	8	not applicable	20200520_TOF1_AF_139_ZeBanC_P2_B4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_139_ZeBanC_P2_B4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_139_ZeBanC_P2_B4.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-21	Homo sapiens	blood plasma	9	not applicable	not available	76	female	not available	COVID-19	Alive	no depletion	9	not applicable	20200520_TOF1_AF_152_ZeBanC_P2_C3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_152_ZeBanC_P2_C3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_152_ZeBanC_P2_C3.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-22	Homo sapiens	blood plasma	9	not applicable	not available	76	female	not available	COVID-19	Alive	no depletion	9	not applicable	20200520_TOF1_AF_153_ZeBanC_P2_C4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_153_ZeBanC_P2_C4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_153_ZeBanC_P2_C4.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-23	Homo sapiens	blood plasma	9	not applicable	not available	76	female	not available	COVID-19	Alive	no depletion	9	not applicable	20200520_TOF1_AF_170_ZeBanC_P2_D5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_170_ZeBanC_P2_D5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_170_ZeBanC_P2_D5.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-24	Homo sapiens	blood plasma	9	not applicable	not available	76	female	not available	COVID-19	Alive	no depletion	9	not applicable	20200520_TOF1_AF_202_ZeBanC_P2_F7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_202_ZeBanC_P2_F7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_202_ZeBanC_P2_F7.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-25	Homo sapiens	blood plasma	9	not applicable	not available	76	female	not available	COVID-19	Alive	no depletion	9	not applicable	20200520_TOF1_AF_221_ZeBanC_P2_G10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_221_ZeBanC_P2_G10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_221_ZeBanC_P2_G10.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-26	Homo sapiens	blood plasma	10	not applicable	not available	53	male	not available	COVID-19	Alive	no depletion	10	not applicable	20200520_TOF1_AF_328_ZeBanC_P3_B3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_328_ZeBanC_P3_B3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_328_ZeBanC_P3_B3.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-27	Homo sapiens	blood plasma	10	not applicable	not available	53	male	not available	COVID-19	Alive	no depletion	10	not applicable	20200520_TOF1_AF_343_ZeBanC_P3_C1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_343_ZeBanC_P3_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_343_ZeBanC_P3_C1.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-28	Homo sapiens	blood plasma	10	not applicable	not available	53	male	not available	COVID-19	Alive	no depletion	10	not applicable	20200520_TOF1_AF_395_ZeBanC_P3_F8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_395_ZeBanC_P3_F8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_395_ZeBanC_P3_F8.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-29	Homo sapiens	blood plasma	11	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	11	not applicable	20200520_TOF1_AF_436_ZeBanC_P4_A4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_436_ZeBanC_P4_A4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_436_ZeBanC_P4_A4.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-30	Homo sapiens	blood plasma	11	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	11	not applicable	20200520_TOF1_AF_477_ZeBanC_P4_D2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_477_ZeBanC_P4_D2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_477_ZeBanC_P4_D2.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-31	Homo sapiens	blood plasma	11	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	11	not applicable	20200520_TOF1_AF_479_ZeBanC_P4_D3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_479_ZeBanC_P4_D3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_479_ZeBanC_P4_D3.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-32	Homo sapiens	blood plasma	11	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	11	not applicable	20200520_TOF1_AF_494_ZeBanC_P4_E4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_494_ZeBanC_P4_E4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_494_ZeBanC_P4_E4.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-33	Homo sapiens	blood plasma	11	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	11	not applicable	20200520_TOF1_AF_504_ZeBanC_P4_E11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_504_ZeBanC_P4_E11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_504_ZeBanC_P4_E11.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-34	Homo sapiens	blood plasma	11	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	11	not applicable	20200520_TOF1_AF_506_ZeBanC_P4_F1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_506_ZeBanC_P4_F1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_506_ZeBanC_P4_F1.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-35	Homo sapiens	blood plasma	12	not applicable	not available	25	female	not available	COVID-19	Alive	no depletion	12	not applicable	20200520_TOF1_AF_023_ZeBanC_P1_B7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_023_ZeBanC_P1_B7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_023_ZeBanC_P1_B7.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-36	Homo sapiens	blood plasma	13	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	13	not applicable	20200520_TOF1_AF_526_ZeBanC_P4_G6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_526_ZeBanC_P4_G6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_526_ZeBanC_P4_G6.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-37	Homo sapiens	blood plasma	14	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	14	not applicable	20200520_TOF1_AF_555_ZeBanC_P6_A5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_555_ZeBanC_P6_A5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_555_ZeBanC_P6_A5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-38	Homo sapiens	blood plasma	14	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	14	not applicable	20200520_TOF1_AF_572_ZeBanC_P6_C3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_572_ZeBanC_P6_C3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_572_ZeBanC_P6_C3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-39	Homo sapiens	blood plasma	14	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	14	not applicable	20200520_TOF1_AF_576_ZeBanC_P6_C7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_576_ZeBanC_P6_C7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_576_ZeBanC_P6_C7.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-40	Homo sapiens	blood plasma	14	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	14	not applicable	20200520_TOF1_AF_581_ZeBanC_P6_D1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_581_ZeBanC_P6_D1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_581_ZeBanC_P6_D1.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-41	Homo sapiens	blood plasma	14	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	14	not applicable	20200520_TOF1_AF_604_ZeBanC_P6_F6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_604_ZeBanC_P6_F6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_604_ZeBanC_P6_F6.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-42	Homo sapiens	blood plasma	14	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	14	not applicable	20200520_TOF1_AF_605_ZeBanC_P6_F7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_605_ZeBanC_P6_F7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_605_ZeBanC_P6_F7.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-43	Homo sapiens	blood plasma	15	not applicable	not available	86	male	not available	COVID-19	Dead	no depletion	15	not applicable	20200520_TOF1_AF_132_ZeBanC_P2_A10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_132_ZeBanC_P2_A10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_132_ZeBanC_P2_A10.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-44	Homo sapiens	blood plasma	15	not applicable	not available	86	male	not available	COVID-19	Dead	no depletion	15	not applicable	20200520_TOF1_AF_141_ZeBanC_P2_B6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_141_ZeBanC_P2_B6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_141_ZeBanC_P2_B6.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-45	Homo sapiens	blood plasma	15	not applicable	not available	86	male	not available	COVID-19	Dead	no depletion	15	not applicable	20200520_TOF1_AF_185_ZeBanC_P2_E6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_185_ZeBanC_P2_E6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_185_ZeBanC_P2_E6.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-46	Homo sapiens	blood plasma	15	not applicable	not available	86	male	not available	COVID-19	Dead	no depletion	15	not applicable	20200520_TOF1_AF_194_ZeBanC_P2_E12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_194_ZeBanC_P2_E12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_194_ZeBanC_P2_E12.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-47	Homo sapiens	blood plasma	15	not applicable	not available	86	male	not available	COVID-19	Dead	no depletion	15	not applicable	20200520_TOF1_AF_197_ZeBanC_P2_F3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_197_ZeBanC_P2_F3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_197_ZeBanC_P2_F3.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-48	Homo sapiens	blood plasma	15	not applicable	not available	86	male	not available	COVID-19	Dead	no depletion	15	not applicable	20200520_TOF1_AF_228_ZeBanC_P2_H4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_228_ZeBanC_P2_H4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_228_ZeBanC_P2_H4.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-49	Homo sapiens	blood plasma	16	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	16	not applicable	20200520_TOF1_AF_337_ZeBanC_P3_B10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_337_ZeBanC_P3_B10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_337_ZeBanC_P3_B10.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-50	Homo sapiens	blood plasma	16	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	16	not applicable	20200520_TOF1_AF_398_ZeBanC_P3_F10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_398_ZeBanC_P3_F10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_398_ZeBanC_P3_F10.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-51	Homo sapiens	blood plasma	16	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	16	not applicable	20200520_TOF1_AF_429_ZeBanC_P3_H11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_429_ZeBanC_P3_H11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_429_ZeBanC_P3_H11.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-52	Homo sapiens	blood plasma	17	not applicable	not available	52	male	not available	COVID-19	Alive	no depletion	17	not applicable	20200520_TOF1_AF_367_ZeBanC_P3_D9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_367_ZeBanC_P3_D9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_367_ZeBanC_P3_D9.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-53	Homo sapiens	blood plasma	17	not applicable	not available	52	male	not available	COVID-19	Alive	no depletion	17	not applicable	20200520_TOF1_AF_405_ZeBanC_P3_G3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_405_ZeBanC_P3_G3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_405_ZeBanC_P3_G3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-54	Homo sapiens	blood plasma	17	not applicable	not available	52	male	not available	COVID-19	Alive	no depletion	17	not applicable	20200520_TOF1_AF_409_ZeBanC_P3_G7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_409_ZeBanC_P3_G7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_409_ZeBanC_P3_G7.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-55	Homo sapiens	blood plasma	17	not applicable	not available	52	male	not available	COVID-19	Alive	no depletion	17	not applicable	20200520_TOF1_AF_413_ZeBanC_P3_G10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_413_ZeBanC_P3_G10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_413_ZeBanC_P3_G10.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-56	Homo sapiens	blood plasma	18	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	18	not applicable	20200520_TOF1_AF_148_ZeBanC_P2_B12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_148_ZeBanC_P2_B12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_148_ZeBanC_P2_B12.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-57	Homo sapiens	blood plasma	18	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	18	not applicable	20200520_TOF1_AF_189_ZeBanC_P2_E8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_189_ZeBanC_P2_E8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_189_ZeBanC_P2_E8.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-58	Homo sapiens	blood plasma	18	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	18	not applicable	20200520_TOF1_AF_214_ZeBanC_P2_G5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_214_ZeBanC_P2_G5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_214_ZeBanC_P2_G5.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-59	Homo sapiens	blood plasma	19	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	19	not applicable	20200520_TOF1_AF_136_ZeBanC_P2_B2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_136_ZeBanC_P2_B2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_136_ZeBanC_P2_B2.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-60	Homo sapiens	blood plasma	19	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	19	not applicable	20200520_TOF1_AF_142_ZeBanC_P2_B7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_142_ZeBanC_P2_B7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_142_ZeBanC_P2_B7.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-61	Homo sapiens	blood plasma	19	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	19	not applicable	20200520_TOF1_AF_146_ZeBanC_P2_B10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_146_ZeBanC_P2_B10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_146_ZeBanC_P2_B10.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-62	Homo sapiens	blood plasma	19	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	19	not applicable	20200520_TOF1_AF_164_ZeBanC_P2_C12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_164_ZeBanC_P2_C12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_164_ZeBanC_P2_C12.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-63	Homo sapiens	blood plasma	19	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	19	not applicable	20200520_TOF1_AF_215_ZeBanC_P2_G6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_215_ZeBanC_P2_G6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_215_ZeBanC_P2_G6.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-64	Homo sapiens	blood plasma	19	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	19	not applicable	20200520_TOF1_AF_226_ZeBanC_P2_H2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_226_ZeBanC_P2_H2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_226_ZeBanC_P2_H2.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-65	Homo sapiens	blood plasma	19	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	19	not applicable	20200520_TOF1_AF_229_ZeBanC_P2_H5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_229_ZeBanC_P2_H5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_229_ZeBanC_P2_H5.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-66	Homo sapiens	blood plasma	20	not applicable	not available	50	female	not available	COVID-19	Alive	no depletion	20	not applicable	20200520_TOF1_AF_530_ZeBanC_P4_G8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_530_ZeBanC_P4_G8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_530_ZeBanC_P4_G8.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-67	Homo sapiens	blood plasma	21	not applicable	not available	86	male	not available	COVID-19	Dead	no depletion	21	not applicable	20200520_TOF1_AF_481_ZeBanC_P4_D5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_481_ZeBanC_P4_D5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_481_ZeBanC_P4_D5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-68	Homo sapiens	blood plasma	21	not applicable	not available	86	male	not available	COVID-19	Dead	no depletion	21	not applicable	20200520_TOF1_AF_547_ZeBanC_P4_H10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_547_ZeBanC_P4_H10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_547_ZeBanC_P4_H10.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-69	Homo sapiens	blood plasma	22	not applicable	not available	84	male	not available	COVID-19	Alive	no depletion	22	not applicable	20200520_TOF1_AF_363_ZeBanC_P3_D6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_363_ZeBanC_P3_D6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_363_ZeBanC_P3_D6.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-70	Homo sapiens	blood plasma	23	not applicable	not available	50	female	not available	COVID-19	Dead	no depletion	23	not applicable	20200520_TOF1_AF_450_ZeBanC_P4_B4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_450_ZeBanC_P4_B4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_450_ZeBanC_P4_B4.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-71	Homo sapiens	blood plasma	23	not applicable	not available	50	female	not available	COVID-19	Dead	no depletion	23	not applicable	20200520_TOF1_AF_471_ZeBanC_P4_C9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_471_ZeBanC_P4_C9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_471_ZeBanC_P4_C9.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-72	Homo sapiens	blood plasma	23	not applicable	not available	50	female	not available	COVID-19	Dead	no depletion	23	not applicable	20200520_TOF1_AF_475_ZeBanC_P4_C12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_475_ZeBanC_P4_C12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_475_ZeBanC_P4_C12.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-73	Homo sapiens	blood plasma	23	not applicable	not available	50	female	not available	COVID-19	Dead	no depletion	23	not applicable	20200520_TOF1_AF_482_ZeBanC_P4_D6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_482_ZeBanC_P4_D6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_482_ZeBanC_P4_D6.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-74	Homo sapiens	blood plasma	23	not applicable	not available	50	female	not available	COVID-19	Dead	no depletion	23	not applicable	20200520_TOF1_AF_544_ZeBanC_P4_H8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_544_ZeBanC_P4_H8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_544_ZeBanC_P4_H8.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-75	Homo sapiens	blood plasma	24	not applicable	not available	59	male	not available	COVID-19	Alive	no depletion	24	not applicable	20200520_TOF1_AF_147_ZeBanC_P2_B11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_147_ZeBanC_P2_B11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_147_ZeBanC_P2_B11.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-76	Homo sapiens	blood plasma	24	not applicable	not available	59	male	not available	COVID-19	Alive	no depletion	24	not applicable	20200520_TOF1_AF_200_ZeBanC_P2_F5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_200_ZeBanC_P2_F5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_200_ZeBanC_P2_F5.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-77	Homo sapiens	blood plasma	24	not applicable	not available	59	male	not available	COVID-19	Alive	no depletion	24	not applicable	20200520_TOF1_AF_219_ZeBanC_P2_G8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_219_ZeBanC_P2_G8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_219_ZeBanC_P2_G8.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-78	Homo sapiens	blood plasma	25	not applicable	not available	26	male	not available	COVID-19	Alive	no depletion	25	not applicable	20200520_TOF1_AF_315_ZeBanC_P3_A3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_315_ZeBanC_P3_A3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_315_ZeBanC_P3_A3.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-79	Homo sapiens	blood plasma	25	not applicable	not available	26	male	not available	COVID-19	Alive	no depletion	25	not applicable	20200520_TOF1_AF_330_ZeBanC_P3_B4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_330_ZeBanC_P3_B4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_330_ZeBanC_P3_B4.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-80	Homo sapiens	blood plasma	25	not applicable	not available	26	male	not available	COVID-19	Alive	no depletion	25	not applicable	20200520_TOF1_AF_332_ZeBanC_P3_B6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_332_ZeBanC_P3_B6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_332_ZeBanC_P3_B6.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-81	Homo sapiens	blood plasma	25	not applicable	not available	26	male	not available	COVID-19	Alive	no depletion	25	not applicable	20200520_TOF1_AF_352_ZeBanC_P3_C9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_352_ZeBanC_P3_C9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_352_ZeBanC_P3_C9.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-82	Homo sapiens	blood plasma	25	not applicable	not available	26	male	not available	COVID-19	Alive	no depletion	25	not applicable	20200520_TOF1_AF_369_ZeBanC_P3_D11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_369_ZeBanC_P3_D11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_369_ZeBanC_P3_D11.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-83	Homo sapiens	blood plasma	25	not applicable	not available	26	male	not available	COVID-19	Alive	no depletion	25	not applicable	20200520_TOF1_AF_374_ZeBanC_P3_E2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_374_ZeBanC_P3_E2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_374_ZeBanC_P3_E2.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-84	Homo sapiens	blood plasma	25	not applicable	not available	26	male	not available	COVID-19	Alive	no depletion	25	not applicable	20200520_TOF1_AF_390_ZeBanC_P3_F4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_390_ZeBanC_P3_F4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_390_ZeBanC_P3_F4.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-85	Homo sapiens	blood plasma	25	not applicable	not available	26	male	not available	COVID-19	Alive	no depletion	25	not applicable	20200520_TOF1_AF_401_ZeBanC_P3_G1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_401_ZeBanC_P3_G1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_401_ZeBanC_P3_G1.raw	1	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-86	Homo sapiens	blood plasma	26	not applicable	not available	69	female	not available	COVID-19	Alive	no depletion	26	not applicable	20200520_TOF1_AF_003_ZeBanC_P1_A2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_003_ZeBanC_P1_A2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_003_ZeBanC_P1_A2.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-87	Homo sapiens	blood plasma	26	not applicable	not available	69	female	not available	COVID-19	Alive	no depletion	26	not applicable	20200520_TOF1_AF_004_ZeBanC_P1_A3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_004_ZeBanC_P1_A3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_004_ZeBanC_P1_A3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-88	Homo sapiens	blood plasma	26	not applicable	not available	69	female	not available	COVID-19	Alive	no depletion	26	not applicable	20200520_TOF1_AF_011_ZeBanC_P1_A9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_011_ZeBanC_P1_A9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_011_ZeBanC_P1_A9.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-89	Homo sapiens	blood plasma	26	not applicable	not available	69	female	not available	COVID-19	Alive	no depletion	26	not applicable	20200520_TOF1_AF_058_ZeBanC_P1_D11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_058_ZeBanC_P1_D11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_058_ZeBanC_P1_D11.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-90	Homo sapiens	blood plasma	26	not applicable	not available	69	female	not available	COVID-19	Alive	no depletion	26	not applicable	20200520_TOF1_AF_088_ZeBanC_P1_F11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_088_ZeBanC_P1_F11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_088_ZeBanC_P1_F11.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-91	Homo sapiens	blood plasma	27	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	27	not applicable	20200520_TOF1_AF_020_ZeBanC_P1_B4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_020_ZeBanC_P1_B4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_020_ZeBanC_P1_B4.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-92	Homo sapiens	blood plasma	27	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	27	not applicable	20200520_TOF1_AF_024_ZeBanC_P1_B8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_024_ZeBanC_P1_B8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_024_ZeBanC_P1_B8.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-93	Homo sapiens	blood plasma	27	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	27	not applicable	20200520_TOF1_AF_029_ZeBanC_P1_B12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_029_ZeBanC_P1_B12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_029_ZeBanC_P1_B12.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-94	Homo sapiens	blood plasma	27	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	27	not applicable	20200520_TOF1_AF_064_ZeBanC_P1_E3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_064_ZeBanC_P1_E3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_064_ZeBanC_P1_E3.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-95	Homo sapiens	blood plasma	27	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	27	not applicable	20200520_TOF1_AF_066_ZeBanC_P1_E5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_066_ZeBanC_P1_E5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_066_ZeBanC_P1_E5.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-96	Homo sapiens	blood plasma	28	not applicable	not available	47	male	not available	COVID-19	Alive	no depletion	28	not applicable	20200520_TOF1_AF_072_ZeBanC_P1_E10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_072_ZeBanC_P1_E10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_072_ZeBanC_P1_E10.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-97	Homo sapiens	blood plasma	28	not applicable	not available	47	male	not available	COVID-19	Alive	no depletion	28	not applicable	20200520_TOF1_AF_080_ZeBanC_P1_F5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_080_ZeBanC_P1_F5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_080_ZeBanC_P1_F5.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-98	Homo sapiens	blood plasma	29	not applicable	not available	59	male	not available	COVID-19	Alive	no depletion	29	not applicable	20200520_TOF1_AF_463_ZeBanC_P4_C3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_463_ZeBanC_P4_C3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_463_ZeBanC_P4_C3.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-99	Homo sapiens	blood plasma	29	not applicable	not available	59	male	not available	COVID-19	Alive	no depletion	29	not applicable	20200520_TOF1_AF_487_ZeBanC_P4_D10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_487_ZeBanC_P4_D10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_487_ZeBanC_P4_D10.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-100	Homo sapiens	blood plasma	29	not applicable	not available	59	male	not available	COVID-19	Alive	no depletion	29	not applicable	20200520_TOF1_AF_545_ZeBanC_P4_H9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_545_ZeBanC_P4_H9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_545_ZeBanC_P4_H9.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-101	Homo sapiens	blood plasma	30	not applicable	not available	76	male	not available	COVID-19	Alive	no depletion	30	not applicable	20200520_TOF1_AF_440_ZeBanC_P4_A8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_440_ZeBanC_P4_A8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_440_ZeBanC_P4_A8.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-102	Homo sapiens	blood plasma	30	not applicable	not available	76	male	not available	COVID-19	Alive	no depletion	30	not applicable	20200520_TOF1_AF_523_ZeBanC_P4_G3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_523_ZeBanC_P4_G3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_523_ZeBanC_P4_G3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-103	Homo sapiens	blood plasma	30	not applicable	not available	76	male	not available	COVID-19	Alive	no depletion	30	not applicable	20200520_TOF1_AF_537_ZeBanC_P4_H2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_537_ZeBanC_P4_H2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_537_ZeBanC_P4_H2.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-104	Homo sapiens	blood plasma	31	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	31	not applicable	20200520_TOF1_AF_351_ZeBanC_P3_C8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_351_ZeBanC_P3_C8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_351_ZeBanC_P3_C8.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-105	Homo sapiens	blood plasma	31	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	31	not applicable	20200520_TOF1_AF_357_ZeBanC_P3_D1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_357_ZeBanC_P3_D1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_357_ZeBanC_P3_D1.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-106	Homo sapiens	blood plasma	31	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	31	not applicable	20200520_TOF1_AF_389_ZeBanC_P3_F3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_389_ZeBanC_P3_F3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_389_ZeBanC_P3_F3.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-107	Homo sapiens	blood plasma	32	not applicable	not available	22	female	not available	COVID-19	Alive	no depletion	32	not applicable	20200520_TOF1_AF_134_ZeBanC_P2_A12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_134_ZeBanC_P2_A12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_134_ZeBanC_P2_A12.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-108	Homo sapiens	blood plasma	32	not applicable	not available	22	female	not available	COVID-19	Alive	no depletion	32	not applicable	20200520_TOF1_AF_192_ZeBanC_P2_E11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_192_ZeBanC_P2_E11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_192_ZeBanC_P2_E11.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-109	Homo sapiens	blood plasma	32	not applicable	not available	22	female	not available	COVID-19	Alive	no depletion	32	not applicable	20200520_TOF1_AF_232_ZeBanC_P2_H7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_232_ZeBanC_P2_H7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_232_ZeBanC_P2_H7.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-110	Homo sapiens	blood plasma	33	not applicable	not available	79	female	not available	COVID-19	Alive	no depletion	33	not applicable	20200520_TOF1_AF_045_ZeBanC_P1_C12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_045_ZeBanC_P1_C12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_045_ZeBanC_P1_C12.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-111	Homo sapiens	blood plasma	34	not applicable	not available	71	male	not available	COVID-19	Dead	no depletion	34	not applicable	20200520_TOF1_AF_432_ZeBanC_P4_A2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_432_ZeBanC_P4_A2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_432_ZeBanC_P4_A2.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-112	Homo sapiens	blood plasma	34	not applicable	not available	71	male	not available	COVID-19	Dead	no depletion	34	not applicable	20200520_TOF1_AF_433_ZeBanC_P4_A3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_433_ZeBanC_P4_A3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_433_ZeBanC_P4_A3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-113	Homo sapiens	blood plasma	34	not applicable	not available	71	male	not available	COVID-19	Dead	no depletion	34	not applicable	20200520_TOF1_AF_451_ZeBanC_P4_B5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_451_ZeBanC_P4_B5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_451_ZeBanC_P4_B5.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-114	Homo sapiens	blood plasma	34	not applicable	not available	71	male	not available	COVID-19	Dead	no depletion	34	not applicable	20200520_TOF1_AF_469_ZeBanC_P4_C7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_469_ZeBanC_P4_C7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_469_ZeBanC_P4_C7.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-115	Homo sapiens	blood plasma	34	not applicable	not available	71	male	not available	COVID-19	Dead	no depletion	34	not applicable	20200520_TOF1_AF_485_ZeBanC_P4_D8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_485_ZeBanC_P4_D8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_485_ZeBanC_P4_D8.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-116	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_561_ZeBanC_P6_A9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_561_ZeBanC_P6_A9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_561_ZeBanC_P6_A9.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-117	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_585_ZeBanC_P6_D4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_585_ZeBanC_P6_D4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_585_ZeBanC_P6_D4.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-118	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_586_ZeBanC_P6_D5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_586_ZeBanC_P6_D5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_586_ZeBanC_P6_D5.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-119	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_594_ZeBanC_P6_E4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_594_ZeBanC_P6_E4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_594_ZeBanC_P6_E4.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-120	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_595_ZeBanC_P6_E5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_595_ZeBanC_P6_E5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_595_ZeBanC_P6_E5.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-121	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_598_ZeBanC_P6_E7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_598_ZeBanC_P6_E7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_598_ZeBanC_P6_E7.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-122	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_603_ZeBanC_P6_F5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_603_ZeBanC_P6_F5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_603_ZeBanC_P6_F5.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-123	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_606_ZeBanC_P6_F9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_606_ZeBanC_P6_F9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_606_ZeBanC_P6_F9.raw	1	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-124	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_607_ZeBanC_P6_F11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_607_ZeBanC_P6_F11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_607_ZeBanC_P6_F11.raw	1	AC=MS:1002038;NT=label free sample	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-125	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_609_ZeBanC_P6_F12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_609_ZeBanC_P6_F12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_609_ZeBanC_P6_F12.raw	1	AC=MS:1002038;NT=label free sample	10	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-126	Homo sapiens	blood plasma	35	not applicable	not available	80	female	not available	COVID-19	Alive	no depletion	35	not applicable	20200520_TOF1_AF_622_ZeBanC_P6_H5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_622_ZeBanC_P6_H5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_622_ZeBanC_P6_H5.raw	1	AC=MS:1002038;NT=label free sample	11	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-127	Homo sapiens	blood plasma	36	not applicable	not available	68	male	not available	COVID-19	Alive	no depletion	36	not applicable	20200520_TOF1_AF_047_ZeBanC_P1_D2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_047_ZeBanC_P1_D2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_047_ZeBanC_P1_D2.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-128	Homo sapiens	blood plasma	36	not applicable	not available	68	male	not available	COVID-19	Alive	no depletion	36	not applicable	20200520_TOF1_AF_061_ZeBanC_P1_E2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_061_ZeBanC_P1_E2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_061_ZeBanC_P1_E2.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-129	Homo sapiens	blood plasma	36	not applicable	not available	68	male	not available	COVID-19	Alive	no depletion	36	not applicable	20200520_TOF1_AF_091_ZeBanC_P1_G2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_091_ZeBanC_P1_G2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_091_ZeBanC_P1_G2.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-130	Homo sapiens	blood plasma	37	not applicable	not available	62	male	not available	COVID-19	Alive	no depletion	37	not applicable	20200520_TOF1_AF_562_ZeBanC_P6_A12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_562_ZeBanC_P6_A12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_562_ZeBanC_P6_A12.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-131	Homo sapiens	blood plasma	37	not applicable	not available	62	male	not available	COVID-19	Alive	no depletion	37	not applicable	20200520_TOF1_AF_563_ZeBanC_P6_B1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_563_ZeBanC_P6_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_563_ZeBanC_P6_B1.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-132	Homo sapiens	blood plasma	37	not applicable	not available	62	male	not available	COVID-19	Alive	no depletion	37	not applicable	20200520_TOF1_AF_564_ZeBanC_P6_B4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_564_ZeBanC_P6_B4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_564_ZeBanC_P6_B4.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-133	Homo sapiens	blood plasma	38	not applicable	not available	81	male	not available	COVID-19	Alive	no depletion	38	not applicable	20200520_TOF1_AF_027_ZeBanC_P1_B10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_027_ZeBanC_P1_B10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_027_ZeBanC_P1_B10.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-134	Homo sapiens	blood plasma	38	not applicable	not available	81	male	not available	COVID-19	Alive	no depletion	38	not applicable	20200520_TOF1_AF_039_ZeBanC_P1_C7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_039_ZeBanC_P1_C7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_039_ZeBanC_P1_C7.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-135	Homo sapiens	blood plasma	38	not applicable	not available	81	male	not available	COVID-19	Alive	no depletion	38	not applicable	20200520_TOF1_AF_117_ZeBanC_P1_H11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_117_ZeBanC_P1_H11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_117_ZeBanC_P1_H11.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-136	Homo sapiens	blood plasma	39	not applicable	not available	84	male	not available	COVID-19	Alive	no depletion	39	not applicable	20200520_TOF1_AF_539_ZeBanC_P4_H4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_539_ZeBanC_P4_H4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_539_ZeBanC_P4_H4.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-137	Homo sapiens	blood plasma	40	not applicable	not available	65	female	not available	COVID-19	Alive	no depletion	40	not applicable	20200520_TOF1_AF_313_ZeBanC_P3_A1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_313_ZeBanC_P3_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_313_ZeBanC_P3_A1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-138	Homo sapiens	blood plasma	40	not applicable	not available	65	female	not available	COVID-19	Alive	no depletion	40	not applicable	20200520_TOF1_AF_353_ZeBanC_P3_C10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_353_ZeBanC_P3_C10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_353_ZeBanC_P3_C10.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-139	Homo sapiens	blood plasma	41	not applicable	not available	48	male	not available	COVID-19	Alive	no depletion	41	not applicable	20200520_TOF1_AF_319_ZeBanC_P3_A6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_319_ZeBanC_P3_A6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_319_ZeBanC_P3_A6.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-140	Homo sapiens	blood plasma	41	not applicable	not available	48	male	not available	COVID-19	Alive	no depletion	41	not applicable	20200520_TOF1_AF_350_ZeBanC_P3_C7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_350_ZeBanC_P3_C7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_350_ZeBanC_P3_C7.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-141	Homo sapiens	blood plasma	41	not applicable	not available	48	male	not available	COVID-19	Alive	no depletion	41	not applicable	20200520_TOF1_AF_358_ZeBanC_P3_D2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_358_ZeBanC_P3_D2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_358_ZeBanC_P3_D2.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-142	Homo sapiens	blood plasma	42	not applicable	not available	61	male	not available	COVID-19	Alive	no depletion	42	not applicable	20200520_TOF1_AF_033_ZeBanC_P1_C2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_033_ZeBanC_P1_C2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_033_ZeBanC_P1_C2.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-143	Homo sapiens	blood plasma	42	not applicable	not available	61	male	not available	COVID-19	Alive	no depletion	42	not applicable	20200520_TOF1_AF_067_ZeBanC_P1_E6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_067_ZeBanC_P1_E6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_067_ZeBanC_P1_E6.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-144	Homo sapiens	blood plasma	42	not applicable	not available	61	male	not available	COVID-19	Alive	no depletion	42	not applicable	20200520_TOF1_AF_077_ZeBanC_P1_F2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_077_ZeBanC_P1_F2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_077_ZeBanC_P1_F2.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-145	Homo sapiens	blood plasma	42	not applicable	not available	61	male	not available	COVID-19	Alive	no depletion	42	not applicable	20200520_TOF1_AF_108_ZeBanC_P1_H3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_108_ZeBanC_P1_H3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_108_ZeBanC_P1_H3.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-146	Homo sapiens	blood plasma	43	not applicable	not available	79	male	not available	COVID-19	Alive	no depletion	43	not applicable	20200520_TOF1_AF_030_ZeBanC_P1_C1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_030_ZeBanC_P1_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_030_ZeBanC_P1_C1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-147	Homo sapiens	blood plasma	44	not applicable	not available	66	male	not available	COVID-19	Alive	no depletion	44	not applicable	20200520_TOF1_AF_322_ZeBanC_P3_A9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_322_ZeBanC_P3_A9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_322_ZeBanC_P3_A9.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-148	Homo sapiens	blood plasma	44	not applicable	not available	66	male	not available	COVID-19	Alive	no depletion	44	not applicable	20200520_TOF1_AF_412_ZeBanC_P3_G9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_412_ZeBanC_P3_G9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_412_ZeBanC_P3_G9.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-149	Homo sapiens	blood plasma	44	not applicable	not available	66	male	not available	COVID-19	Alive	no depletion	44	not applicable	20200520_TOF1_AF_415_ZeBanC_P3_G12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_415_ZeBanC_P3_G12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_415_ZeBanC_P3_G12.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-150	Homo sapiens	blood plasma	45	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	45	not applicable	20200520_TOF1_AF_184_ZeBanC_P2_E5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_184_ZeBanC_P2_E5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_184_ZeBanC_P2_E5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-151	Homo sapiens	blood plasma	45	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	45	not applicable	20200520_TOF1_AF_233_ZeBanC_P2_H8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_233_ZeBanC_P2_H8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_233_ZeBanC_P2_H8.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-152	Homo sapiens	blood plasma	46	not applicable	not available	38	female	not available	COVID-19	Alive	no depletion	46	not applicable	20200520_TOF1_AF_438_ZeBanC_P4_A6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_438_ZeBanC_P4_A6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_438_ZeBanC_P4_A6.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-153	Homo sapiens	blood plasma	46	not applicable	not available	38	female	not available	COVID-19	Alive	no depletion	46	not applicable	20200520_TOF1_AF_508_ZeBanC_P4_F3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_508_ZeBanC_P4_F3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_508_ZeBanC_P4_F3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-154	Homo sapiens	blood plasma	47	not applicable	not available	56	female	not available	COVID-19	Dead	no depletion	47	not applicable	20200520_TOF1_AF_567_ZeBanC_P6_B9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_567_ZeBanC_P6_B9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_567_ZeBanC_P6_B9.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-155	Homo sapiens	blood plasma	47	not applicable	not available	56	female	not available	COVID-19	Dead	no depletion	47	not applicable	20200520_TOF1_AF_569_ZeBanC_P6_C1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_569_ZeBanC_P6_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_569_ZeBanC_P6_C1.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-156	Homo sapiens	blood plasma	47	not applicable	not available	56	female	not available	COVID-19	Dead	no depletion	47	not applicable	20200520_TOF1_AF_573_ZeBanC_P6_C4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_573_ZeBanC_P6_C4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_573_ZeBanC_P6_C4.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-157	Homo sapiens	blood plasma	47	not applicable	not available	56	female	not available	COVID-19	Dead	no depletion	47	not applicable	20200520_TOF1_AF_591_ZeBanC_P6_D11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_591_ZeBanC_P6_D11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_591_ZeBanC_P6_D11.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-158	Homo sapiens	blood plasma	47	not applicable	not available	56	female	not available	COVID-19	Dead	no depletion	47	not applicable	20200520_TOF1_AF_601_ZeBanC_P6_F2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_601_ZeBanC_P6_F2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_601_ZeBanC_P6_F2.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-159	Homo sapiens	blood plasma	48	not applicable	not available	70	female	not available	COVID-19	Alive	no depletion	48	not applicable	20200520_TOF1_AF_173_ZeBanC_P2_D8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_173_ZeBanC_P2_D8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_173_ZeBanC_P2_D8.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-160	Homo sapiens	blood plasma	48	not applicable	not available	70	female	not available	COVID-19	Alive	no depletion	48	not applicable	20200520_TOF1_AF_183_ZeBanC_P2_E4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_183_ZeBanC_P2_E4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_183_ZeBanC_P2_E4.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-161	Homo sapiens	blood plasma	48	not applicable	not available	70	female	not available	COVID-19	Alive	no depletion	48	not applicable	20200520_TOF1_AF_222_ZeBanC_P2_G11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_222_ZeBanC_P2_G11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_222_ZeBanC_P2_G11.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-162	Homo sapiens	blood plasma	49	not applicable	not available	73	male	not available	COVID-19	Alive	no depletion	49	not applicable	20200520_TOF1_AF_460_ZeBanC_P4_B12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_460_ZeBanC_P4_B12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_460_ZeBanC_P4_B12.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-163	Homo sapiens	blood plasma	49	not applicable	not available	73	male	not available	COVID-19	Alive	no depletion	49	not applicable	20200520_TOF1_AF_480_ZeBanC_P4_D4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_480_ZeBanC_P4_D4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_480_ZeBanC_P4_D4.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-164	Homo sapiens	blood plasma	49	not applicable	not available	73	male	not available	COVID-19	Alive	no depletion	49	not applicable	20200520_TOF1_AF_483_ZeBanC_P4_D7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_483_ZeBanC_P4_D7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_483_ZeBanC_P4_D7.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-165	Homo sapiens	blood plasma	49	not applicable	not available	73	male	not available	COVID-19	Alive	no depletion	49	not applicable	20200520_TOF1_AF_489_ZeBanC_P4_D12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_489_ZeBanC_P4_D12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_489_ZeBanC_P4_D12.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-166	Homo sapiens	blood plasma	49	not applicable	not available	73	male	not available	COVID-19	Alive	no depletion	49	not applicable	20200520_TOF1_AF_493_ZeBanC_P4_E3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_493_ZeBanC_P4_E3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_493_ZeBanC_P4_E3.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-167	Homo sapiens	blood plasma	49	not applicable	not available	73	male	not available	COVID-19	Alive	no depletion	49	not applicable	20200520_TOF1_AF_500_ZeBanC_P4_E8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_500_ZeBanC_P4_E8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_500_ZeBanC_P4_E8.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-168	Homo sapiens	blood plasma	50	not applicable	not available	77	male	not available	COVID-19	Alive	no depletion	50	not applicable	20200520_TOF1_AF_042_ZeBanC_P1_C10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_042_ZeBanC_P1_C10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_042_ZeBanC_P1_C10.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-169	Homo sapiens	blood plasma	51	not applicable	not available	62	male	not available	COVID-19	Alive	no depletion	51	not applicable	20200520_TOF1_AF_570_ZeBanC_P6_C2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_570_ZeBanC_P6_C2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_570_ZeBanC_P6_C2.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-170	Homo sapiens	blood plasma	51	not applicable	not available	62	male	not available	COVID-19	Alive	no depletion	51	not applicable	20200520_TOF1_AF_575_ZeBanC_P6_C6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_575_ZeBanC_P6_C6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_575_ZeBanC_P6_C6.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-171	Homo sapiens	blood plasma	52	not applicable	not available	55	male	not available	COVID-19	Alive	no depletion	52	not applicable	20200520_TOF1_AF_431_ZeBanC_P4_A1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_431_ZeBanC_P4_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_431_ZeBanC_P4_A1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-172	Homo sapiens	blood plasma	52	not applicable	not available	55	male	not available	COVID-19	Alive	no depletion	52	not applicable	20200520_TOF1_AF_443_ZeBanC_P4_A10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_443_ZeBanC_P4_A10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_443_ZeBanC_P4_A10.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-173	Homo sapiens	blood plasma	53	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	53	not applicable	20200520_TOF1_AF_579_ZeBanC_P6_C9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_579_ZeBanC_P6_C9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_579_ZeBanC_P6_C9.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-174	Homo sapiens	blood plasma	53	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	53	not applicable	20200520_TOF1_AF_584_ZeBanC_P6_D3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_584_ZeBanC_P6_D3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_584_ZeBanC_P6_D3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-175	Homo sapiens	blood plasma	53	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	53	not applicable	20200520_TOF1_AF_593_ZeBanC_P6_E3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_593_ZeBanC_P6_E3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_593_ZeBanC_P6_E3.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-176	Homo sapiens	blood plasma	53	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	53	not applicable	20200520_TOF1_AF_611_ZeBanC_P6_G2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_611_ZeBanC_P6_G2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_611_ZeBanC_P6_G2.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-177	Homo sapiens	blood plasma	53	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	53	not applicable	20200520_TOF1_AF_612_ZeBanC_P6_G3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_612_ZeBanC_P6_G3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_612_ZeBanC_P6_G3.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-178	Homo sapiens	blood plasma	53	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	53	not applicable	20200520_TOF1_AF_625_ZeBanC_P6_H11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_625_ZeBanC_P6_H11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_625_ZeBanC_P6_H11.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-179	Homo sapiens	blood plasma	54	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	54	not applicable	20200520_TOF1_AF_126_ZeBanC_P2_A5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_126_ZeBanC_P2_A5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_126_ZeBanC_P2_A5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-180	Homo sapiens	blood plasma	54	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	54	not applicable	20200520_TOF1_AF_140_ZeBanC_P2_B5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_140_ZeBanC_P2_B5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_140_ZeBanC_P2_B5.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-181	Homo sapiens	blood plasma	54	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	54	not applicable	20200520_TOF1_AF_159_ZeBanC_P2_C8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_159_ZeBanC_P2_C8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_159_ZeBanC_P2_C8.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-182	Homo sapiens	blood plasma	54	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	54	not applicable	20200520_TOF1_AF_166_ZeBanC_P2_D2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_166_ZeBanC_P2_D2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_166_ZeBanC_P2_D2.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-183	Homo sapiens	blood plasma	54	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	54	not applicable	20200520_TOF1_AF_172_ZeBanC_P2_D7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_172_ZeBanC_P2_D7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_172_ZeBanC_P2_D7.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-184	Homo sapiens	blood plasma	54	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	54	not applicable	20200520_TOF1_AF_206_ZeBanC_P2_F10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_206_ZeBanC_P2_F10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_206_ZeBanC_P2_F10.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-185	Homo sapiens	blood plasma	54	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	54	not applicable	20200520_TOF1_AF_212_ZeBanC_P2_G3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_212_ZeBanC_P2_G3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_212_ZeBanC_P2_G3.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-186	Homo sapiens	blood plasma	54	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	54	not applicable	20200520_TOF1_AF_213_ZeBanC_P2_G4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_213_ZeBanC_P2_G4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_213_ZeBanC_P2_G4.raw	1	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-187	Homo sapiens	blood plasma	54	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	54	not applicable	20200520_TOF1_AF_227_ZeBanC_P2_H3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_227_ZeBanC_P2_H3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_227_ZeBanC_P2_H3.raw	1	AC=MS:1002038;NT=label free sample	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-188	Homo sapiens	blood plasma	55	not applicable	not available	73	male	not available	COVID-19	Alive	no depletion	55	not applicable	20200520_TOF1_AF_216_ZeBanC_P2_G7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_216_ZeBanC_P2_G7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_216_ZeBanC_P2_G7.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-189	Homo sapiens	blood plasma	55	not applicable	not available	73	male	not available	COVID-19	Alive	no depletion	55	not applicable	20200520_TOF1_AF_237_ZeBanC_P2_H11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_237_ZeBanC_P2_H11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_237_ZeBanC_P2_H11.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-190	Homo sapiens	blood plasma	56	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	56	not applicable	20200520_TOF1_AF_318_ZeBanC_P3_A5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_318_ZeBanC_P3_A5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_318_ZeBanC_P3_A5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-191	Homo sapiens	blood plasma	56	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	56	not applicable	20200520_TOF1_AF_333_ZeBanC_P3_B7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_333_ZeBanC_P3_B7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_333_ZeBanC_P3_B7.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-192	Homo sapiens	blood plasma	56	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	56	not applicable	20200520_TOF1_AF_336_ZeBanC_P3_B9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_336_ZeBanC_P3_B9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_336_ZeBanC_P3_B9.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-193	Homo sapiens	blood plasma	56	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	56	not applicable	20200520_TOF1_AF_339_ZeBanC_P3_B11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_339_ZeBanC_P3_B11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_339_ZeBanC_P3_B11.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-194	Homo sapiens	blood plasma	56	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	56	not applicable	20200520_TOF1_AF_346_ZeBanC_P3_C4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_346_ZeBanC_P3_C4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_346_ZeBanC_P3_C4.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-195	Homo sapiens	blood plasma	56	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	56	not applicable	20200520_TOF1_AF_377_ZeBanC_P3_E5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_377_ZeBanC_P3_E5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_377_ZeBanC_P3_E5.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-196	Homo sapiens	blood plasma	56	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	56	not applicable	20200520_TOF1_AF_382_ZeBanC_P3_E9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_382_ZeBanC_P3_E9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_382_ZeBanC_P3_E9.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-197	Homo sapiens	blood plasma	56	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	56	not applicable	20200520_TOF1_AF_396_ZeBanC_P3_F9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_396_ZeBanC_P3_F9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_396_ZeBanC_P3_F9.raw	1	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-198	Homo sapiens	blood plasma	56	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	56	not applicable	20200520_TOF1_AF_400_ZeBanC_P3_F12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_400_ZeBanC_P3_F12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_400_ZeBanC_P3_F12.raw	1	AC=MS:1002038;NT=label free sample	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-199	Homo sapiens	blood plasma	56	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	56	not applicable	20200520_TOF1_AF_414_ZeBanC_P3_G11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_414_ZeBanC_P3_G11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_414_ZeBanC_P3_G11.raw	1	AC=MS:1002038;NT=label free sample	10	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-200	Homo sapiens	blood plasma	57	not applicable	not available	62	male	not available	COVID-19	Alive	no depletion	57	not applicable	20200520_TOF1_AF_345_ZeBanC_P3_C3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_345_ZeBanC_P3_C3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_345_ZeBanC_P3_C3.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-201	Homo sapiens	blood plasma	57	not applicable	not available	62	male	not available	COVID-19	Alive	no depletion	57	not applicable	20200520_TOF1_AF_383_ZeBanC_P3_E10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_383_ZeBanC_P3_E10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_383_ZeBanC_P3_E10.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-202	Homo sapiens	blood plasma	58	not applicable	not available	76	male	not available	COVID-19	Dead	no depletion	58	not applicable	20200520_TOF1_AF_364_ZeBanC_P3_D7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_364_ZeBanC_P3_D7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_364_ZeBanC_P3_D7.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-203	Homo sapiens	blood plasma	58	not applicable	not available	76	male	not available	COVID-19	Dead	no depletion	58	not applicable	20200520_TOF1_AF_423_ZeBanC_P3_H6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_423_ZeBanC_P3_H6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_423_ZeBanC_P3_H6.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-204	Homo sapiens	blood plasma	59	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	59	not applicable	20200520_TOF1_AF_018_ZeBanC_P1_B3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_018_ZeBanC_P1_B3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_018_ZeBanC_P1_B3.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-205	Homo sapiens	blood plasma	59	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	59	not applicable	20200520_TOF1_AF_035_ZeBanC_P1_C4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_035_ZeBanC_P1_C4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_035_ZeBanC_P1_C4.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-206	Homo sapiens	blood plasma	59	not applicable	not available	75	male	not available	COVID-19	Alive	no depletion	59	not applicable	20200520_TOF1_AF_105_ZeBanC_P1_H1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_105_ZeBanC_P1_H1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_105_ZeBanC_P1_H1.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-207	Homo sapiens	blood plasma	60	not applicable	not available	40	female	not available	COVID-19	Alive	no depletion	60	not applicable	20200520_TOF1_AF_470_ZeBanC_P4_C8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_470_ZeBanC_P4_C8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_470_ZeBanC_P4_C8.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-208	Homo sapiens	blood plasma	61	not applicable	not available	40	male	not available	COVID-19	Alive	no depletion	61	not applicable	20200520_TOF1_AF_135_ZeBanC_P2_B1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_135_ZeBanC_P2_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_135_ZeBanC_P2_B1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-209	Homo sapiens	blood plasma	61	not applicable	not available	40	male	not available	COVID-19	Alive	no depletion	61	not applicable	20200520_TOF1_AF_138_ZeBanC_P2_B3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_138_ZeBanC_P2_B3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_138_ZeBanC_P2_B3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-210	Homo sapiens	blood plasma	62	not applicable	not available	41	male	not available	COVID-19	Alive	no depletion	62	not applicable	20200520_TOF1_AF_365_ZeBanC_P3_D8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_365_ZeBanC_P3_D8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_365_ZeBanC_P3_D8.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-211	Homo sapiens	blood plasma	63	not applicable	not available	52	male	not available	COVID-19	Alive	no depletion	63	not applicable	20200520_TOF1_AF_119_ZeBanC_P1_H12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_119_ZeBanC_P1_H12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_119_ZeBanC_P1_H12.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-212	Homo sapiens	blood plasma	64	not applicable	not available	68	female	not available	COVID-19	Alive	no depletion	64	not applicable	20200520_TOF1_AF_195_ZeBanC_P2_F1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_195_ZeBanC_P2_F1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_195_ZeBanC_P2_F1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-213	Homo sapiens	blood plasma	65	not applicable	not available	74	male	not available	COVID-19	Dead	no depletion	65	not applicable	20200520_TOF1_AF_551_ZeBanC_P6_A2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_551_ZeBanC_P6_A2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_551_ZeBanC_P6_A2.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-214	Homo sapiens	blood plasma	65	not applicable	not available	74	male	not available	COVID-19	Dead	no depletion	65	not applicable	20200520_TOF1_AF_560_ZeBanC_P6_A8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_560_ZeBanC_P6_A8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_560_ZeBanC_P6_A8.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-215	Homo sapiens	blood plasma	65	not applicable	not available	74	male	not available	COVID-19	Dead	no depletion	65	not applicable	20200520_TOF1_AF_580_ZeBanC_P6_C12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_580_ZeBanC_P6_C12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_580_ZeBanC_P6_C12.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-216	Homo sapiens	blood plasma	65	not applicable	not available	74	male	not available	COVID-19	Dead	no depletion	65	not applicable	20200520_TOF1_AF_588_ZeBanC_P6_D10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_588_ZeBanC_P6_D10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_588_ZeBanC_P6_D10.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-217	Homo sapiens	blood plasma	65	not applicable	not available	74	male	not available	COVID-19	Dead	no depletion	65	not applicable	20200520_TOF1_AF_592_ZeBanC_P6_D12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_592_ZeBanC_P6_D12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_592_ZeBanC_P6_D12.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-218	Homo sapiens	blood plasma	65	not applicable	not available	74	male	not available	COVID-19	Dead	no depletion	65	not applicable	20200520_TOF1_AF_616_ZeBanC_P6_G10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_616_ZeBanC_P6_G10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_616_ZeBanC_P6_G10.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-219	Homo sapiens	blood plasma	65	not applicable	not available	74	male	not available	COVID-19	Dead	no depletion	65	not applicable	20200520_TOF1_AF_617_ZeBanC_P6_G11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_617_ZeBanC_P6_G11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_617_ZeBanC_P6_G11.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-220	Homo sapiens	blood plasma	65	not applicable	not available	74	male	not available	COVID-19	Dead	no depletion	65	not applicable	20200520_TOF1_AF_618_ZeBanC_P6_H2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_618_ZeBanC_P6_H2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_618_ZeBanC_P6_H2.raw	1	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-221	Homo sapiens	blood plasma	65	not applicable	not available	74	male	not available	COVID-19	Dead	no depletion	65	not applicable	20200520_TOF1_AF_626_ZeBanC_P6_H12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_626_ZeBanC_P6_H12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_626_ZeBanC_P6_H12.raw	1	AC=MS:1002038;NT=label free sample	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-222	Homo sapiens	blood plasma	66	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	66	not applicable	20200520_TOF1_AF_437_ZeBanC_P4_A5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_437_ZeBanC_P4_A5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_437_ZeBanC_P4_A5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-223	Homo sapiens	blood plasma	66	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	66	not applicable	20200520_TOF1_AF_444_ZeBanC_P4_A11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_444_ZeBanC_P4_A11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_444_ZeBanC_P4_A11.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-224	Homo sapiens	blood plasma	66	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	66	not applicable	20200520_TOF1_AF_457_ZeBanC_P4_B10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_457_ZeBanC_P4_B10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_457_ZeBanC_P4_B10.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-225	Homo sapiens	blood plasma	66	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	66	not applicable	20200520_TOF1_AF_464_ZeBanC_P4_C4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_464_ZeBanC_P4_C4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_464_ZeBanC_P4_C4.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-226	Homo sapiens	blood plasma	66	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	66	not applicable	20200520_TOF1_AF_467_ZeBanC_P4_C5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_467_ZeBanC_P4_C5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_467_ZeBanC_P4_C5.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-227	Homo sapiens	blood plasma	66	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	66	not applicable	20200520_TOF1_AF_488_ZeBanC_P4_D11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_488_ZeBanC_P4_D11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_488_ZeBanC_P4_D11.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-228	Homo sapiens	blood plasma	66	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	66	not applicable	20200520_TOF1_AF_492_ZeBanC_P4_E2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_492_ZeBanC_P4_E2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_492_ZeBanC_P4_E2.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-229	Homo sapiens	blood plasma	66	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	66	not applicable	20200520_TOF1_AF_499_ZeBanC_P4_E7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_499_ZeBanC_P4_E7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_499_ZeBanC_P4_E7.raw	1	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-230	Homo sapiens	blood plasma	66	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	66	not applicable	20200520_TOF1_AF_507_ZeBanC_P4_F2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_507_ZeBanC_P4_F2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_507_ZeBanC_P4_F2.raw	1	AC=MS:1002038;NT=label free sample	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-231	Homo sapiens	blood plasma	66	not applicable	not available	58	male	not available	COVID-19	Alive	no depletion	66	not applicable	20200520_TOF1_AF_524_ZeBanC_P4_G4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_524_ZeBanC_P4_G4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_524_ZeBanC_P4_G4.raw	1	AC=MS:1002038;NT=label free sample	10	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-232	Homo sapiens	blood plasma	67	not applicable	not available	56	male	not available	COVID-19	Alive	no depletion	67	not applicable	20200520_TOF1_AF_014_ZeBanC_P1_A11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_014_ZeBanC_P1_A11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_014_ZeBanC_P1_A11.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-233	Homo sapiens	blood plasma	67	not applicable	not available	56	male	not available	COVID-19	Alive	no depletion	67	not applicable	20200520_TOF1_AF_059_ZeBanC_P1_D12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_059_ZeBanC_P1_D12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_059_ZeBanC_P1_D12.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-234	Homo sapiens	blood plasma	67	not applicable	not available	56	male	not available	COVID-19	Alive	no depletion	67	not applicable	20200520_TOF1_AF_060_ZeBanC_P1_E1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_060_ZeBanC_P1_E1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_060_ZeBanC_P1_E1.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-235	Homo sapiens	blood plasma	67	not applicable	not available	56	male	not available	COVID-19	Alive	no depletion	67	not applicable	20200520_TOF1_AF_099_ZeBanC_P1_G8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_099_ZeBanC_P1_G8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_099_ZeBanC_P1_G8.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-236	Homo sapiens	blood plasma	68	not applicable	not available	92	male	not available	COVID-19	Dead	no depletion	68	not applicable	20200520_TOF1_AF_120_ZeBanC_P2_A1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_120_ZeBanC_P2_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_120_ZeBanC_P2_A1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-237	Homo sapiens	blood plasma	68	not applicable	not available	92	male	not available	COVID-19	Dead	no depletion	68	not applicable	20200520_TOF1_AF_234_ZeBanC_P2_H9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_234_ZeBanC_P2_H9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_234_ZeBanC_P2_H9.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-238	Homo sapiens	blood plasma	69	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	69	not applicable	20200520_TOF1_AF_566_ZeBanC_P6_B6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_566_ZeBanC_P6_B6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_566_ZeBanC_P6_B6.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-239	Homo sapiens	blood plasma	69	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	69	not applicable	20200520_TOF1_AF_568_ZeBanC_P6_B11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_568_ZeBanC_P6_B11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_568_ZeBanC_P6_B11.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-240	Homo sapiens	blood plasma	69	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	69	not applicable	20200520_TOF1_AF_587_ZeBanC_P6_D6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_587_ZeBanC_P6_D6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_587_ZeBanC_P6_D6.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-241	Homo sapiens	blood plasma	70	not applicable	not available	91	male	not available	COVID-19	Alive	no depletion	70	not applicable	20200520_TOF1_AF_378_ZeBanC_P3_E6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_378_ZeBanC_P3_E6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_378_ZeBanC_P3_E6.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-242	Homo sapiens	blood plasma	71	not applicable	not available	77	male	not available	COVID-19	Dead	no depletion	71	not applicable	20200520_TOF1_AF_316_ZeBanC_P3_A4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_316_ZeBanC_P3_A4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_316_ZeBanC_P3_A4.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-243	Homo sapiens	blood plasma	71	not applicable	not available	77	male	not available	COVID-19	Dead	no depletion	71	not applicable	20200520_TOF1_AF_356_ZeBanC_P3_C12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_356_ZeBanC_P3_C12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_356_ZeBanC_P3_C12.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-244	Homo sapiens	blood plasma	72	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	72	not applicable	20200520_TOF1_AF_445_ZeBanC_P4_A12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_445_ZeBanC_P4_A12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_445_ZeBanC_P4_A12.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-245	Homo sapiens	blood plasma	72	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	72	not applicable	20200520_TOF1_AF_448_ZeBanC_P4_B2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_448_ZeBanC_P4_B2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_448_ZeBanC_P4_B2.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-246	Homo sapiens	blood plasma	72	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	72	not applicable	20200520_TOF1_AF_476_ZeBanC_P4_D1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_476_ZeBanC_P4_D1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_476_ZeBanC_P4_D1.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-247	Homo sapiens	blood plasma	72	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	72	not applicable	20200520_TOF1_AF_548_ZeBanC_P4_H11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_548_ZeBanC_P4_H11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_548_ZeBanC_P4_H11.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-248	Homo sapiens	blood plasma	73	not applicable	not available	81	male	not available	COVID-19	Dead	no depletion	73	not applicable	20200520_TOF1_AF_006_ZeBanC_P1_A5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_006_ZeBanC_P1_A5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_006_ZeBanC_P1_A5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-249	Homo sapiens	blood plasma	73	not applicable	not available	81	male	not available	COVID-19	Dead	no depletion	73	not applicable	20200520_TOF1_AF_010_ZeBanC_P1_A8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_010_ZeBanC_P1_A8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_010_ZeBanC_P1_A8.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-250	Homo sapiens	blood plasma	73	not applicable	not available	81	male	not available	COVID-19	Dead	no depletion	73	not applicable	20200520_TOF1_AF_022_ZeBanC_P1_B6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_022_ZeBanC_P1_B6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_022_ZeBanC_P1_B6.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-251	Homo sapiens	blood plasma	73	not applicable	not available	81	male	not available	COVID-19	Dead	no depletion	73	not applicable	20200520_TOF1_AF_041_ZeBanC_P1_C9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_041_ZeBanC_P1_C9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_041_ZeBanC_P1_C9.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-252	Homo sapiens	blood plasma	73	not applicable	not available	81	male	not available	COVID-19	Dead	no depletion	73	not applicable	20200520_TOF1_AF_065_ZeBanC_P1_E4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_065_ZeBanC_P1_E4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_065_ZeBanC_P1_E4.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-253	Homo sapiens	blood plasma	73	not applicable	not available	81	male	not available	COVID-19	Dead	no depletion	73	not applicable	20200520_TOF1_AF_068_ZeBanC_P1_E7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_068_ZeBanC_P1_E7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_068_ZeBanC_P1_E7.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-254	Homo sapiens	blood plasma	74	not applicable	not available	53	female	not available	COVID-19	Alive	no depletion	74	not applicable	20200520_TOF1_AF_314_ZeBanC_P3_A2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_314_ZeBanC_P3_A2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_314_ZeBanC_P3_A2.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-255	Homo sapiens	blood plasma	74	not applicable	not available	53	female	not available	COVID-19	Alive	no depletion	74	not applicable	20200520_TOF1_AF_320_ZeBanC_P3_A7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_320_ZeBanC_P3_A7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_320_ZeBanC_P3_A7.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-256	Homo sapiens	blood plasma	74	not applicable	not available	53	female	not available	COVID-19	Alive	no depletion	74	not applicable	20200520_TOF1_AF_334_ZeBanC_P3_B8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_334_ZeBanC_P3_B8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_334_ZeBanC_P3_B8.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-257	Homo sapiens	blood plasma	75	not applicable	not available	67	female	not available	COVID-19	Dead	no depletion	75	not applicable	20200520_TOF1_AF_361_ZeBanC_P3_D4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_361_ZeBanC_P3_D4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_361_ZeBanC_P3_D4.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-258	Homo sapiens	blood plasma	75	not applicable	not available	67	female	not available	COVID-19	Dead	no depletion	75	not applicable	20200520_TOF1_AF_387_ZeBanC_P3_F1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_387_ZeBanC_P3_F1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_387_ZeBanC_P3_F1.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-259	Homo sapiens	blood plasma	75	not applicable	not available	67	female	not available	COVID-19	Dead	no depletion	75	not applicable	20200520_TOF1_AF_393_ZeBanC_P3_F6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_393_ZeBanC_P3_F6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_393_ZeBanC_P3_F6.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-260	Homo sapiens	blood plasma	75	not applicable	not available	67	female	not available	COVID-19	Dead	no depletion	75	not applicable	20200520_TOF1_AF_408_ZeBanC_P3_G6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_408_ZeBanC_P3_G6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_408_ZeBanC_P3_G6.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-261	Homo sapiens	blood plasma	75	not applicable	not available	67	female	not available	COVID-19	Dead	no depletion	75	not applicable	20200520_TOF1_AF_426_ZeBanC_P3_H9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_426_ZeBanC_P3_H9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_426_ZeBanC_P3_H9.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-262	Homo sapiens	blood plasma	76	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	76	not applicable	20200520_TOF1_AF_239_ZeBanC_P5_A1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_239_ZeBanC_P5_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_239_ZeBanC_P5_A1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-263	Homo sapiens	blood plasma	76	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	76	not applicable	20200520_TOF1_AF_278_ZeBanC_P5_E11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_278_ZeBanC_P5_E11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_278_ZeBanC_P5_E11.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-264	Homo sapiens	blood plasma	76	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	76	not applicable	20200520_TOF1_AF_283_ZeBanC_P5_F6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_283_ZeBanC_P5_F6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_283_ZeBanC_P5_F6.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-265	Homo sapiens	blood plasma	76	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	76	not applicable	20200520_TOF1_AF_287_ZeBanC_P5_F10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_287_ZeBanC_P5_F10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_287_ZeBanC_P5_F10.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-266	Homo sapiens	blood plasma	76	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	76	not applicable	20200520_TOF1_AF_289_ZeBanC_P5_F12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_289_ZeBanC_P5_F12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_289_ZeBanC_P5_F12.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-267	Homo sapiens	blood plasma	76	not applicable	not available	71	male	not available	COVID-19	Alive	no depletion	76	not applicable	20200520_TOF1_AF_297_ZeBanC_P5_G8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_297_ZeBanC_P5_G8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_297_ZeBanC_P5_G8.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-268	Homo sapiens	blood plasma	77	not applicable	not available	70	male	not available	COVID-19	Alive	no depletion	77	not applicable	20200520_TOF1_AF_324_ZeBanC_P3_A10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_324_ZeBanC_P3_A10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_324_ZeBanC_P3_A10.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-269	Homo sapiens	blood plasma	77	not applicable	not available	70	male	not available	COVID-19	Alive	no depletion	77	not applicable	20200520_TOF1_AF_340_ZeBanC_P3_B12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_340_ZeBanC_P3_B12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_340_ZeBanC_P3_B12.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-270	Homo sapiens	blood plasma	77	not applicable	not available	70	male	not available	COVID-19	Alive	no depletion	77	not applicable	20200520_TOF1_AF_411_ZeBanC_P3_G8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_411_ZeBanC_P3_G8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_411_ZeBanC_P3_G8.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-271	Homo sapiens	blood plasma	78	not applicable	not available	27	male	not available	COVID-19	Alive	no depletion	78	not applicable	20200520_TOF1_AF_513_ZeBanC_P4_F7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_513_ZeBanC_P4_F7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_513_ZeBanC_P4_F7.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-272	Homo sapiens	blood plasma	78	not applicable	not available	27	male	not available	COVID-19	Alive	no depletion	78	not applicable	20200520_TOF1_AF_514_ZeBanC_P4_F8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_514_ZeBanC_P4_F8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_514_ZeBanC_P4_F8.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-273	Homo sapiens	blood plasma	79	not applicable	not available	61	male	not available	COVID-19	Alive	no depletion	79	not applicable	20200520_TOF1_AF_036_ZeBanC_P1_C5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_036_ZeBanC_P1_C5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_036_ZeBanC_P1_C5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-274	Homo sapiens	blood plasma	79	not applicable	not available	61	male	not available	COVID-19	Alive	no depletion	79	not applicable	20200520_TOF1_AF_037_ZeBanC_P1_C6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_037_ZeBanC_P1_C6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_037_ZeBanC_P1_C6.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-275	Homo sapiens	blood plasma	79	not applicable	not available	61	male	not available	COVID-19	Alive	no depletion	79	not applicable	20200520_TOF1_AF_076_ZeBanC_P1_F1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_076_ZeBanC_P1_F1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_076_ZeBanC_P1_F1.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-276	Homo sapiens	blood plasma	79	not applicable	not available	61	male	not available	COVID-19	Alive	no depletion	79	not applicable	20200520_TOF1_AF_089_ZeBanC_P1_F12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_089_ZeBanC_P1_F12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_089_ZeBanC_P1_F12.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-277	Homo sapiens	blood plasma	79	not applicable	not available	61	male	not available	COVID-19	Alive	no depletion	79	not applicable	20200520_TOF1_AF_096_ZeBanC_P1_G5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_096_ZeBanC_P1_G5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_096_ZeBanC_P1_G5.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-278	Homo sapiens	blood plasma	79	not applicable	not available	61	male	not available	COVID-19	Alive	no depletion	79	not applicable	20200520_TOF1_AF_104_ZeBanC_P1_G12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_104_ZeBanC_P1_G12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_104_ZeBanC_P1_G12.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-279	Homo sapiens	blood plasma	80	not applicable	not available	71	female	not available	COVID-19	Alive	no depletion	80	not applicable	20200520_TOF1_AF_188_ZeBanC_P2_E7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_188_ZeBanC_P2_E7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_188_ZeBanC_P2_E7.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-280	Homo sapiens	blood plasma	80	not applicable	not available	71	female	not available	COVID-19	Alive	no depletion	80	not applicable	20200520_TOF1_AF_225_ZeBanC_P2_H1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_225_ZeBanC_P2_H1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_225_ZeBanC_P2_H1.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-281	Homo sapiens	blood plasma	81	not applicable	not available	21	male	not available	COVID-19	Alive	no depletion	81	not applicable	20200520_TOF1_AF_017_ZeBanC_P1_B2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_017_ZeBanC_P1_B2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_017_ZeBanC_P1_B2.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-282	Homo sapiens	blood plasma	81	not applicable	not available	21	male	not available	COVID-19	Alive	no depletion	81	not applicable	20200520_TOF1_AF_055_ZeBanC_P1_D9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_055_ZeBanC_P1_D9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_055_ZeBanC_P1_D9.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-283	Homo sapiens	blood plasma	82	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	82	not applicable	20200520_TOF1_AF_371_ZeBanC_P3_E1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_371_ZeBanC_P3_E1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_371_ZeBanC_P3_E1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-284	Homo sapiens	blood plasma	82	not applicable	not available	54	male	not available	COVID-19	Alive	no depletion	82	not applicable	20200520_TOF1_AF_388_ZeBanC_P3_F2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_388_ZeBanC_P3_F2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_388_ZeBanC_P3_F2.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-285	Homo sapiens	blood plasma	83	not applicable	not available	53	male	not available	COVID-19	Alive	no depletion	83	not applicable	20200520_TOF1_AF_531_ZeBanC_P4_G9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_531_ZeBanC_P4_G9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_531_ZeBanC_P4_G9.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-286	Homo sapiens	blood plasma	84	not applicable	not available	22	male	not available	COVID-19	Alive	no depletion	84	not applicable	20200520_TOF1_AF_074_ZeBanC_P1_E12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_074_ZeBanC_P1_E12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_074_ZeBanC_P1_E12.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-287	Homo sapiens	blood plasma	84	not applicable	not available	22	male	not available	COVID-19	Alive	no depletion	84	not applicable	20200520_TOF1_AF_078_ZeBanC_P1_F3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_078_ZeBanC_P1_F3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_078_ZeBanC_P1_F3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-288	Homo sapiens	blood plasma	84	not applicable	not available	22	male	not available	COVID-19	Alive	no depletion	84	not applicable	20200520_TOF1_AF_082_ZeBanC_P1_F6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_082_ZeBanC_P1_F6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_082_ZeBanC_P1_F6.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-289	Homo sapiens	blood plasma	84	not applicable	not available	22	male	not available	COVID-19	Alive	no depletion	84	not applicable	20200520_TOF1_AF_101_ZeBanC_P1_G9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_101_ZeBanC_P1_G9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_101_ZeBanC_P1_G9.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-290	Homo sapiens	blood plasma	84	not applicable	not available	22	male	not available	COVID-19	Alive	no depletion	84	not applicable	20200520_TOF1_AF_102_ZeBanC_P1_G10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_102_ZeBanC_P1_G10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_102_ZeBanC_P1_G10.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-291	Homo sapiens	blood plasma	85	not applicable	not available	62	female	not available	COVID-19	Alive	no depletion	85	not applicable	20200520_TOF1_AF_090_ZeBanC_P1_G1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_090_ZeBanC_P1_G1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_090_ZeBanC_P1_G1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-292	Homo sapiens	blood plasma	86	not applicable	not available	72	male	not available	COVID-19	Dead	no depletion	86	not applicable	20200520_TOF1_AF_026_ZeBanC_P1_B9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_026_ZeBanC_P1_B9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_026_ZeBanC_P1_B9.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-293	Homo sapiens	blood plasma	86	not applicable	not available	72	male	not available	COVID-19	Dead	no depletion	86	not applicable	20200520_TOF1_AF_028_ZeBanC_P1_B11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_028_ZeBanC_P1_B11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_028_ZeBanC_P1_B11.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-294	Homo sapiens	blood plasma	86	not applicable	not available	72	male	not available	COVID-19	Dead	no depletion	86	not applicable	20200520_TOF1_AF_040_ZeBanC_P1_C8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_040_ZeBanC_P1_C8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_040_ZeBanC_P1_C8.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-295	Homo sapiens	blood plasma	86	not applicable	not available	72	male	not available	COVID-19	Dead	no depletion	86	not applicable	20200520_TOF1_AF_052_ZeBanC_P1_D6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_052_ZeBanC_P1_D6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_052_ZeBanC_P1_D6.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-296	Homo sapiens	blood plasma	86	not applicable	not available	72	male	not available	COVID-19	Dead	no depletion	86	not applicable	20200520_TOF1_AF_057_ZeBanC_P1_D10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_057_ZeBanC_P1_D10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_057_ZeBanC_P1_D10.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-297	Homo sapiens	blood plasma	86	not applicable	not available	72	male	not available	COVID-19	Dead	no depletion	86	not applicable	20200520_TOF1_AF_070_ZeBanC_P1_E8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_070_ZeBanC_P1_E8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_070_ZeBanC_P1_E8.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-298	Homo sapiens	blood plasma	86	not applicable	not available	72	male	not available	COVID-19	Dead	no depletion	86	not applicable	20200520_TOF1_AF_084_ZeBanC_P1_F8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_084_ZeBanC_P1_F8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_084_ZeBanC_P1_F8.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-299	Homo sapiens	blood plasma	86	not applicable	not available	72	male	not available	COVID-19	Dead	no depletion	86	not applicable	20200520_TOF1_AF_115_ZeBanC_P1_H9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_115_ZeBanC_P1_H9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_115_ZeBanC_P1_H9.raw	1	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-300	Homo sapiens	blood plasma	87	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	87	not applicable	20200520_TOF1_AF_110_ZeBanC_P1_H5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_110_ZeBanC_P1_H5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_110_ZeBanC_P1_H5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-301	Homo sapiens	blood plasma	87	not applicable	not available	78	male	not available	COVID-19	Alive	no depletion	87	not applicable	20200520_TOF1_AF_113_ZeBanC_P1_H7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_113_ZeBanC_P1_H7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_113_ZeBanC_P1_H7.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-302	Homo sapiens	blood plasma	88	not applicable	not available	45	male	not available	COVID-19	Alive	no depletion	88	not applicable	20200520_TOF1_AF_442_ZeBanC_P4_A9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_442_ZeBanC_P4_A9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_442_ZeBanC_P4_A9.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-303	Homo sapiens	blood plasma	88	not applicable	not available	45	male	not available	COVID-19	Alive	no depletion	88	not applicable	20200520_TOF1_AF_511_ZeBanC_P4_F5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_511_ZeBanC_P4_F5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_511_ZeBanC_P4_F5.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-304	Homo sapiens	blood plasma	89	not applicable	not available	70	male	not available	COVID-19	Alive	no depletion	89	not applicable	20200520_TOF1_AF_468_ZeBanC_P4_C6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_468_ZeBanC_P4_C6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_468_ZeBanC_P4_C6.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-305	Homo sapiens	blood plasma	89	not applicable	not available	70	male	not available	COVID-19	Alive	no depletion	89	not applicable	20200520_TOF1_AF_473_ZeBanC_P4_C10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_473_ZeBanC_P4_C10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_473_ZeBanC_P4_C10.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-306	Homo sapiens	blood plasma	89	not applicable	not available	70	male	not available	COVID-19	Alive	no depletion	89	not applicable	20200520_TOF1_AF_516_ZeBanC_P4_F9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_516_ZeBanC_P4_F9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_516_ZeBanC_P4_F9.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-307	Homo sapiens	blood plasma	89	not applicable	not available	70	male	not available	COVID-19	Alive	no depletion	89	not applicable	20200520_TOF1_AF_535_ZeBanC_P4_G12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_535_ZeBanC_P4_G12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_535_ZeBanC_P4_G12.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-308	Homo sapiens	blood plasma	90	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	90	not applicable	20200520_TOF1_AF_121_ZeBanC_P2_A2	proteomic profiling by mass spectrometry	20200520_TOF1_AF_121_ZeBanC_P2_A2.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_121_ZeBanC_P2_A2.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-309	Homo sapiens	blood plasma	90	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	90	not applicable	20200520_TOF1_AF_127_ZeBanC_P2_A6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_127_ZeBanC_P2_A6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_127_ZeBanC_P2_A6.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-310	Homo sapiens	blood plasma	90	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	90	not applicable	20200520_TOF1_AF_130_ZeBanC_P2_A9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_130_ZeBanC_P2_A9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_130_ZeBanC_P2_A9.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-311	Homo sapiens	blood plasma	90	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	90	not applicable	20200520_TOF1_AF_133_ZeBanC_P2_A11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_133_ZeBanC_P2_A11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_133_ZeBanC_P2_A11.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-312	Homo sapiens	blood plasma	90	not applicable	not available	67	male	not available	COVID-19	Alive	no depletion	90	not applicable	20200520_TOF1_AF_154_ZeBanC_P2_C5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_154_ZeBanC_P2_C5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_154_ZeBanC_P2_C5.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-313	Homo sapiens	blood plasma	91	not applicable	not available	47	female	not available	COVID-19	Alive	no depletion	91	not applicable	20200520_TOF1_AF_123_ZeBanC_P2_A4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_123_ZeBanC_P2_A4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_123_ZeBanC_P2_A4.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-314	Homo sapiens	blood plasma	91	not applicable	not available	47	female	not available	COVID-19	Alive	no depletion	91	not applicable	20200520_TOF1_AF_207_ZeBanC_P2_F11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_207_ZeBanC_P2_F11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_207_ZeBanC_P2_F11.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-315	Homo sapiens	blood plasma	92	not applicable	not available	60	male	not available	COVID-19	Alive	no depletion	92	not applicable	20200520_TOF1_AF_005_ZeBanC_P1_A4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_005_ZeBanC_P1_A4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_005_ZeBanC_P1_A4.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-316	Homo sapiens	blood plasma	92	not applicable	not available	60	male	not available	COVID-19	Alive	no depletion	92	not applicable	20200520_TOF1_AF_008_ZeBanC_P1_A6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_008_ZeBanC_P1_A6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_008_ZeBanC_P1_A6.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-317	Homo sapiens	blood plasma	92	not applicable	not available	60	male	not available	COVID-19	Alive	no depletion	92	not applicable	20200520_TOF1_AF_048_ZeBanC_P1_D3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_048_ZeBanC_P1_D3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_048_ZeBanC_P1_D3.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-318	Homo sapiens	blood plasma	92	not applicable	not available	60	male	not available	COVID-19	Alive	no depletion	92	not applicable	20200520_TOF1_AF_103_ZeBanC_P1_G11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_103_ZeBanC_P1_G11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_103_ZeBanC_P1_G11.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-319	Homo sapiens	blood plasma	93	not applicable	not available	44	female	not available	COVID-19	Alive	no depletion	93	not applicable	20200520_TOF1_AF_321_ZeBanC_P3_A8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_321_ZeBanC_P3_A8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_321_ZeBanC_P3_A8.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-320	Homo sapiens	blood plasma	93	not applicable	not available	44	female	not available	COVID-19	Alive	no depletion	93	not applicable	20200520_TOF1_AF_384_ZeBanC_P3_E11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_384_ZeBanC_P3_E11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_384_ZeBanC_P3_E11.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-321	Homo sapiens	blood plasma	93	not applicable	not available	44	female	not available	COVID-19	Alive	no depletion	93	not applicable	20200520_TOF1_AF_427_ZeBanC_P3_H10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_427_ZeBanC_P3_H10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_427_ZeBanC_P3_H10.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-322	Homo sapiens	blood plasma	93	not applicable	not available	44	female	not available	COVID-19	Alive	no depletion	93	not applicable	20200520_TOF1_AF_430_ZeBanC_P3_H12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_430_ZeBanC_P3_H12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_430_ZeBanC_P3_H12.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-323	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_247_ZeBanC_P5_A12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_247_ZeBanC_P5_A12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_247_ZeBanC_P5_A12.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-324	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_251_ZeBanC_P5_B3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_251_ZeBanC_P5_B3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_251_ZeBanC_P5_B3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-325	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_258_ZeBanC_P5_B10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_258_ZeBanC_P5_B10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_258_ZeBanC_P5_B10.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-326	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_264_ZeBanC_P5_C7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_264_ZeBanC_P5_C7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_264_ZeBanC_P5_C7.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-327	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_268_ZeBanC_P5_D4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_268_ZeBanC_P5_D4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_268_ZeBanC_P5_D4.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-328	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_269_ZeBanC_P5_D5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_269_ZeBanC_P5_D5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_269_ZeBanC_P5_D5.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-329	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_285_ZeBanC_P5_F8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_285_ZeBanC_P5_F8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_285_ZeBanC_P5_F8.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-330	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_295_ZeBanC_P5_G6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_295_ZeBanC_P5_G6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_295_ZeBanC_P5_G6.raw	1	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-331	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_299_ZeBanC_P5_G9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_299_ZeBanC_P5_G9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_299_ZeBanC_P5_G9.raw	1	AC=MS:1002038;NT=label free sample	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-332	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_307_ZeBanC_P5_H8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_307_ZeBanC_P5_H8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_307_ZeBanC_P5_H8.raw	1	AC=MS:1002038;NT=label free sample	10	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-333	Homo sapiens	blood plasma	94	not applicable	not available	63	male	not available	COVID-19	Alive	no depletion	94	not applicable	20200520_TOF1_AF_308_ZeBanC_P5_H9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_308_ZeBanC_P5_H9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_308_ZeBanC_P5_H9.raw	1	AC=MS:1002038;NT=label free sample	11	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-334	Homo sapiens	blood plasma	95	not applicable	not available	55	female	not available	COVID-19	Alive	no depletion	95	not applicable	20200520_TOF1_AF_525_ZeBanC_P4_G5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_525_ZeBanC_P4_G5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_525_ZeBanC_P4_G5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-335	Homo sapiens	blood plasma	95	not applicable	not available	55	female	not available	COVID-19	Alive	no depletion	95	not applicable	20200520_TOF1_AF_542_ZeBanC_P4_H6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_542_ZeBanC_P4_H6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_542_ZeBanC_P4_H6.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-336	Homo sapiens	blood plasma	96	not applicable	not available	35	female	not available	COVID-19	Alive	no depletion	96	not applicable	20200520_TOF1_AF_456_ZeBanC_P4_B9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_456_ZeBanC_P4_B9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_456_ZeBanC_P4_B9.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-337	Homo sapiens	blood plasma	96	not applicable	not available	35	female	not available	COVID-19	Alive	no depletion	96	not applicable	20200520_TOF1_AF_458_ZeBanC_P4_B11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_458_ZeBanC_P4_B11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_458_ZeBanC_P4_B11.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-338	Homo sapiens	blood plasma	96	not applicable	not available	35	female	not available	COVID-19	Alive	no depletion	96	not applicable	20200520_TOF1_AF_461_ZeBanC_P4_C1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_461_ZeBanC_P4_C1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_461_ZeBanC_P4_C1.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-339	Homo sapiens	blood plasma	96	not applicable	not available	35	female	not available	COVID-19	Alive	no depletion	96	not applicable	20200520_TOF1_AF_501_ZeBanC_P4_E9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_501_ZeBanC_P4_E9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_501_ZeBanC_P4_E9.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-340	Homo sapiens	blood plasma	96	not applicable	not available	35	female	not available	COVID-19	Alive	no depletion	96	not applicable	20200520_TOF1_AF_517_ZeBanC_P4_F10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_517_ZeBanC_P4_F10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_517_ZeBanC_P4_F10.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-341	Homo sapiens	blood plasma	96	not applicable	not available	35	female	not available	COVID-19	Alive	no depletion	96	not applicable	20200520_TOF1_AF_519_ZeBanC_P4_F12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_519_ZeBanC_P4_F12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_519_ZeBanC_P4_F12.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-342	Homo sapiens	blood plasma	96	not applicable	not available	35	female	not available	COVID-19	Alive	no depletion	96	not applicable	20200520_TOF1_AF_549_ZeBanC_P4_H12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_549_ZeBanC_P4_H12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_549_ZeBanC_P4_H12.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-343	Homo sapiens	blood plasma	97	not applicable	not available	62	male	not available	COVID-19	Dead	no depletion	97	not applicable	20200520_TOF1_AF_331_ZeBanC_P3_B5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_331_ZeBanC_P3_B5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_331_ZeBanC_P3_B5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-344	Homo sapiens	blood plasma	98	not applicable	not available	53	male	not available	COVID-19	Dead	no depletion	98	not applicable	20200520_TOF1_AF_002_ZeBanC_P1_A1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_002_ZeBanC_P1_A1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_002_ZeBanC_P1_A1.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-345	Homo sapiens	blood plasma	98	not applicable	not available	53	male	not available	COVID-19	Dead	no depletion	98	not applicable	20200520_TOF1_AF_034_ZeBanC_P1_C3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_034_ZeBanC_P1_C3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_034_ZeBanC_P1_C3.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-346	Homo sapiens	blood plasma	98	not applicable	not available	53	male	not available	COVID-19	Dead	no depletion	98	not applicable	20200520_TOF1_AF_071_ZeBanC_P1_E9	proteomic profiling by mass spectrometry	20200520_TOF1_AF_071_ZeBanC_P1_E9.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_071_ZeBanC_P1_E9.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-347	Homo sapiens	blood plasma	98	not applicable	not available	53	male	not available	COVID-19	Dead	no depletion	98	not applicable	20200520_TOF1_AF_114_ZeBanC_P1_H8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_114_ZeBanC_P1_H8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_114_ZeBanC_P1_H8.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-348	Homo sapiens	blood plasma	99	not applicable	not available	56	male	not available	COVID-19	Alive	no depletion	99	not applicable	20200520_TOF1_AF_380_ZeBanC_P3_E7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_380_ZeBanC_P3_E7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_380_ZeBanC_P3_E7.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-349	Homo sapiens	blood plasma	99	not applicable	not available	56	male	not available	COVID-19	Alive	no depletion	99	not applicable	20200520_TOF1_AF_386_ZeBanC_P3_E12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_386_ZeBanC_P3_E12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_386_ZeBanC_P3_E12.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-350	Homo sapiens	blood plasma	99	not applicable	not available	56	male	not available	COVID-19	Alive	no depletion	99	not applicable	20200520_TOF1_AF_420_ZeBanC_P3_H4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_420_ZeBanC_P3_H4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_420_ZeBanC_P3_H4.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-351	Homo sapiens	blood plasma	99	not applicable	not available	56	male	not available	COVID-19	Alive	no depletion	99	not applicable	20200520_TOF1_AF_425_ZeBanC_P3_H8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_425_ZeBanC_P3_H8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_425_ZeBanC_P3_H8.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-352	Homo sapiens	blood plasma	100	not applicable	not available	36	female	not available	COVID-19	Alive	no depletion	100	not applicable	20200520_TOF1_AF_043_ZeBanC_P1_C11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_043_ZeBanC_P1_C11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_043_ZeBanC_P1_C11.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-353	Homo sapiens	blood plasma	101	not applicable	not available	39	male	not available	COVID-19	Alive	no depletion	101	not applicable	20200520_TOF1_AF_541_ZeBanC_P4_H5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_541_ZeBanC_P4_H5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_541_ZeBanC_P4_H5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-354	Homo sapiens	blood plasma	102	not applicable	not available	71	female	not available	COVID-19	Alive	no depletion	102	not applicable	20200520_TOF1_AF_079_ZeBanC_P1_F4	proteomic profiling by mass spectrometry	20200520_TOF1_AF_079_ZeBanC_P1_F4.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_079_ZeBanC_P1_F4.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-355	Homo sapiens	blood plasma	102	not applicable	not available	71	female	not available	COVID-19	Alive	no depletion	102	not applicable	20200520_TOF1_AF_111_ZeBanC_P1_H6	proteomic profiling by mass spectrometry	20200520_TOF1_AF_111_ZeBanC_P1_H6.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_111_ZeBanC_P1_H6.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-356	Homo sapiens	blood plasma	103	not applicable	not available	51	female	not available	COVID-19	Alive	no depletion	103	not applicable	20200520_TOF1_AF_241_ZeBanC_P5_A5	proteomic profiling by mass spectrometry	20200520_TOF1_AF_241_ZeBanC_P5_A5.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_241_ZeBanC_P5_A5.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-357	Homo sapiens	blood plasma	103	not applicable	not available	51	female	not available	COVID-19	Alive	no depletion	103	not applicable	20200520_TOF1_AF_250_ZeBanC_P5_B1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_250_ZeBanC_P5_B1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_250_ZeBanC_P5_B1.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-358	Homo sapiens	blood plasma	103	not applicable	not available	51	female	not available	COVID-19	Alive	no depletion	103	not applicable	20200520_TOF1_AF_272_ZeBanC_P5_D11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_272_ZeBanC_P5_D11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_272_ZeBanC_P5_D11.raw	1	AC=MS:1002038;NT=label free sample	3	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-359	Homo sapiens	blood plasma	103	not applicable	not available	51	female	not available	COVID-19	Alive	no depletion	103	not applicable	20200520_TOF1_AF_276_ZeBanC_P5_E7	proteomic profiling by mass spectrometry	20200520_TOF1_AF_276_ZeBanC_P5_E7.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_276_ZeBanC_P5_E7.raw	1	AC=MS:1002038;NT=label free sample	4	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-360	Homo sapiens	blood plasma	103	not applicable	not available	51	female	not available	COVID-19	Alive	no depletion	103	not applicable	20200520_TOF1_AF_282_ZeBanC_P5_F3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_282_ZeBanC_P5_F3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_282_ZeBanC_P5_F3.raw	1	AC=MS:1002038;NT=label free sample	5	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-361	Homo sapiens	blood plasma	103	not applicable	not available	51	female	not available	COVID-19	Alive	no depletion	103	not applicable	20200520_TOF1_AF_290_ZeBanC_P5_G1	proteomic profiling by mass spectrometry	20200520_TOF1_AF_290_ZeBanC_P5_G1.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_290_ZeBanC_P5_G1.raw	1	AC=MS:1002038;NT=label free sample	6	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-362	Homo sapiens	blood plasma	103	not applicable	not available	51	female	not available	COVID-19	Alive	no depletion	103	not applicable	20200520_TOF1_AF_293_ZeBanC_P5_G3	proteomic profiling by mass spectrometry	20200520_TOF1_AF_293_ZeBanC_P5_G3.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_293_ZeBanC_P5_G3.raw	1	AC=MS:1002038;NT=label free sample	7	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-363	Homo sapiens	blood plasma	103	not applicable	not available	51	female	not available	COVID-19	Alive	no depletion	103	not applicable	20200520_TOF1_AF_302_ZeBanC_P5_G12	proteomic profiling by mass spectrometry	20200520_TOF1_AF_302_ZeBanC_P5_G12.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_302_ZeBanC_P5_G12.raw	1	AC=MS:1002038;NT=label free sample	8	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-364	Homo sapiens	blood plasma	103	not applicable	not available	51	female	not available	COVID-19	Alive	no depletion	103	not applicable	20200520_TOF1_AF_309_ZeBanC_P5_H11	proteomic profiling by mass spectrometry	20200520_TOF1_AF_309_ZeBanC_P5_H11.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_309_ZeBanC_P5_H11.raw	1	AC=MS:1002038;NT=label free sample	9	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-365	Homo sapiens	blood plasma	104	not applicable	not available	62	male	not available	COVID-19	Alive	no depletion	104	not applicable	20200520_TOF1_AF_161_ZeBanC_P2_C10	proteomic profiling by mass spectrometry	20200520_TOF1_AF_161_ZeBanC_P2_C10.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_161_ZeBanC_P2_C10.raw	1	AC=MS:1002038;NT=label free sample	1	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma
PXD029009-Sample-366	Homo sapiens	blood plasma	104	not applicable	not available	62	male	not available	COVID-19	Alive	no depletion	104	not applicable	20200520_TOF1_AF_203_ZeBanC_P2_F8	proteomic profiling by mass spectrometry	20200520_TOF1_AF_203_ZeBanC_P2_F8.raw	https://www.ebi.ac.uk/pride/archive/projects/PXD029009/20200520_TOF1_AF_203_ZeBanC_P2_F8.raw	1	AC=MS:1002038;NT=label free sample	2	NT=Trypsin; AC=MS:1001251; CS=(?<=[KR])(?!P)	AC=MS:1002533 ; NT=TripleTOF 6600	AC=PRIDE:0000563;NT=Reversed-phase chromatography	NT=Data-Independent Acquisition;AC=PRIDE:0000450	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Variable	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	10 ppm	10 ppm	blood plasma